Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Quinidine

Article Abstract:

Quinidine is a commonly prescribed drug for heart rhythm abnormalities, often used to prevent rapid beating of the heart atria after electrical defibrillation. Quinidine blocks sodium and potassium ion channels in the heart muscle, thereby reducing electrical activity. The drug can be used for atrial arrhythmias and, to a limited extent, for ventricular arrhythmias. A significant complication of quinidine therapy is that the drug may induce a type of ventricle rhythm defect called torsade de pointes. In high-risk patients, close observation may be required when the drug is first used.

Author: Camm, A. John, Grace, Andrew A.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
Complications and side effects, Potassium channels, Arrhythmia, Sodium channels, Quinidine, Anti-arrhythmia drugs, Antiarrhythmia agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Implantable cardioverter-defibrillators (ICD): Expanding indications and technologies

Article Abstract:

The evolving indications for and the numerous advances in implantable cardioverter-defibrillators (ICD) technology are highlighted, with emphasis on primary and secondary prophylaxis of sudden cardiac death (SCD). ICDs are shown to improve survival as both primary and secondary prophylaxis in an expanding population of patients and ongoing ICD research may continue to delineate groups with survival benefit from the ICDs.

Author: Goldberger, Zachary, Lampert, Rachel
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
United States, Usage, Prevention, Cardiac arrest, Sudden cardiac death

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators

Article Abstract:

A study was conducted to examine the effect of supplemental fish oil versus placebo on ventricular tachyarrhythmia or death. The results obtained do not indicate evidence of a strong protective effect of intake of omega-3 polyunsaturated fatty acids (PUFAs) from fish oil against ventricular tachyarrhythmia in patients with implantable cardioverter defibrillators.

Author: Katan, Martijn B., Schouten, Evert G., Camm, A. John, Brouwer, Ingeborg A., Zock, Peter L., Buschler, Helga, Lubinski, Andrzej, Bocker, Dirk, Ronden, Jacintha E., Hauer, Richard N.W., Wever, Eric F.D., Dullemeijer, Carla
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
Dosage and administration, Unsaturated fatty acids, Fish oils, Ventricular tachycardia, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Drug therapy, United States, Implantable cardioverter-defibrillators
Similar abstracts:
  • Abstracts: Emergent (crash) cesarean delivery: Indications and outcomes
  • Abstracts: Adult acne: Troublesome, but treatable. Panic attack: frightening condition is not just 'nerves' or stress. Panic attacks: Scary, but treatable
  • Abstracts: Diagnosis and treatment of cancer of the mouth. Understanding social support for patients with cancer
  • Abstracts: The use of United states vital statistics in perinatal and obstetric research. United States multicenter clinical usage study of the STAN 21 electronic fetal monitoring system
  • Abstracts: Systematic review of the role of external contributors in school substance use education. Gathering and communicating information about school bullying: overcoming 'secrets and lies.'
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.